HospitalAcquired Pneumonia - Biotech, Pharma and Life Science Channel
PubMed Articles
Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study.
We present a case report of long-term response with temsirolimus in cytokine refractory metastatic renal cell carcinoma (RCC). A 74-year-old Japanese man was diagnosed with advanced RCC in November 20...
FEES in the stroke unit : Recommendations for implementation in the clinical routine.
Dysphagia occurs in about 50 % of patients with acute stroke, is strongly related to early complications, such as aspiration pneumonia and is a major cause of increased morbidity and mortality in acu...
A PATIENT WITH ASBESTOSIS, CHOREA AND NEUROPSYCHIATRIC SYMPTOMS: A patient with known asbestosis and a recent chorea was admitted for analysis of increasing disturbances of mobility, memory and social...
Residual gastric volume and risk of ventilator-associated pneumonia--reply.
Residual gastric volume and risk of ventilator-associated pneumonia.
The switch from intravenous to oral antibiotic therapy is recommended for treating hospitalized patients with community-acquired pneumonia (CAP). We performed a multicenter, randomized study to assess...
OBJECTIVES: Human adenovirus (HAdV) type 14 had been infrequently associated with outbreaks of febrile respiratory illness (FRI) until the HAdV-14p1 emerged in 2006 and rapidly spread in the United St...
During the first decade of the twentieth century, the German bacteriologist Fred Neufeld, later Director of the Robert Koch-Institute in Berlin, first described the differentiation of pneumococci into...
BACKGROUND: High rates of bacterial coinfection in autopsy data from the 2009 H1N1 influenza ("flu") pandemic suggest synergies between flu and pneumococcal disease (PD) during pandemic conditions, an...
Opportunistic infections caused by Pneumocystis jirovecii ( P. jirovecii , pj), Toxoplasma gondii ( T. gondii , tg), and Mycobacterium avium ( M. avium , ma) are the principal causes of morbidity and...
News Articles
Series A brings in $8.5mm for [Cardeas Pharma]
[Cardeas Pharma Corp.] (developing inhaled antibiotics for hospital-acquired respiratory infections) raised $8.5mm in its Series A financing led by Novo AS, which was joined by Avalon Ventures, Devon...
WHO: Scientific red tape mars efforts vs. virus
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the...
Antibiotics: A new understanding of sulfonamide nervous system side effects
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects ca...
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped deve...
Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped deve...
Phagenesis Expands Series B Financing to $17 million
Manchester, UK – 22 May 2013 − Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m. In 2011, Phagenesis announced a...
Residual Gastric Volume and Risk of Ventilator-Associated Pneumonia—Reply
In Reply: Despite the data obtained in our trial, Drs Elke and Heyland state that by continuously monitoring residual gastric volume, clinicians can detect more readily patients with delayed gastric e...
Residual Gastric Volume and Risk of Ventilator-Associated Pneumonia
To the Editor: Dr Reignier and colleagues provided evidence that not measuring residual gastric volume and adjusting enteral nutrition except in the case of vomiting or regurgitation (intervention gro...
Company’s Virtual Conjugate Vaccine Program Shows Promise Liquidia Technologies today announced that its collaborative agreement with PATH, a global health nonprofit organiz...
Events
None
Companies
Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...
Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patientâs ability to swallow is damaged....
Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Companyâs proprietary T cell-directed antigen disc...
Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patientâs ability to swallow is damaged....
Curetis AG is a molecular diagnostic company focusing on the development and commercialization of a universal molecular diagnostics solution for easy-to-use, fast and reliable molecular disease test...
Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory...
MiniVax is a New Orleans, LA based company that specializes in the research and development of novel vaccines and therapeutics for the treatment and prevention of opportunistic fu...
Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...
Pulmatrix is discovering and developing a new class of therapies --inhaled cationic airway lining modulators (iCALM) âto prevent and treat respiratory infections and acute ex...
MedImmune Incorporated is a biotechnology company headquartered in Gaithersburg, Maryland with three products on themarket and a diverse product development portfolio. MedImmune is focused on using a...
Clinical Trials
Headache is a common symptom, and patients often seek medical attention at emergency departments due to headaches. The aim of the CoHead Study is to find out if it is possible by measurin...
The Effect of Continuous Versus Enteral Pump Feeding in Aspiration in Tube Fed Patients
Background: Tube feeding had been found to be a cause of aspiration pneumonia. Continuous pump feeding at slower rates as compared to bolus feeding may be less associated with aspiration...
Zithromax EV in Community-Acquired Pneumonia (CAP)
The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP. In fact the International guideli...
Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
The World Health Organization’s (WHO) standard case management strategy for reducing acute respiratory infection (ARI) related mortality recommends oral cotrimoxazole and oral amoxicilli...
Study 0019 (NCT00124020) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Probiotic Enteral Administration in Mechanically Ventilated Patients
The objective of this study is to assess the effects of a daily enteral supplementation with probiotics within a population of critically ill, mechanically ventilated patients. Especially,...
Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia
This was a study involving the emergency department and outpatient clinics of the David Grant United States Air Force (USAF) Medical Center, a tertiary care facility. Patients 18 years of...
Study 0015 (NCT00107952) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Study of Lung Proteins in Patients With Pneumonia
This study will examine the different types of proteins present in the lungs of patients with pneumonia to explore the causes of different types of the disease. Pneumonia is a condition th...
Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory, demyelinating disease which affects the central nervous system (CNS). The etiology of MS is unknown, although the immune system appears to play...
Videos
Hospital Acquired Pneumonia
Full video of LAVC nursing students about Hospital Acquired Pneumonia. The other one is incomplete and was uploaded months ago...
Medical and Biotech [MESH] Definitions
Neisseria Meningitidis, Serogroup Y
Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.
Severe Acute Respiratory Syndrome
A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
Pneumocystis Jirovecii
A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.
Mycoplasma Dispar
A species of gram-negative bacteria causing PNEUMONIA, MYCOPLASMA in calves. Mycoplasma dispar also possibly plays a synergistic role with other BACTERIA and VIRUSES to cause other RESPIRATORY TRACT DISEASES in calves.
Mycoplasma Hyopneumoniae
A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.
